You are Trying to View a Free Article

Daily News You Can't Find Anywhere Else

FDA Targets Generics Manufacturer Mylan for Continuous Quality Problems, an Industrial Info Market Brief

default

Industry Segment: Market Brief | Word Count: 193 Words
Attachment: mylan

Generics manufacturer Mylan once enjoyed an ongoing clean safety record with the U.S. Food and Drug Administration (FDA). Today, the company is finding itself repeatedly in the agency's spotlight due to problems with quality. With a vast global network of manufacturing plants, the company produces active pharmaceutical ingredients (APIs) for a wide range of generic drug products, along with final formulations.

Subscribe Now! All Fields Required...

Standard Membership - Free